{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-022999","form_type":"8-K","ticker":"TECX","cik":"0001681087","company_name":"Tectonic Therapeutic, Inc.","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.816487+00:00","generated_at":"2026-06-25T02:48:29.641484+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.15,"confidence":"high","headline":"AVROBIO stockholders approve plan amendment increasing authorized shares to 13,486,099","bullets":["Elected Gail Farfel, Christopher Paige, and Philip Vickers as Class I directors with over 20M votes each.","Ratified Ernst & Young as independent auditor for FY2022 with 33.8M votes for, 57,906 against.","Approved amendment to 2018 Stock Plan adding 13,486,099 shares and imposing 12-month minimum vesting (excluding 5% pool).","Shares forfeited after March 2, 2022 will be added back to the plan reserve under the amended terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-022999","json":"https://secwatch.observer/filing/0001564590-22-022999.json","markdown":"https://secwatch.observer/filing/0001564590-22-022999.md","text":"https://secwatch.observer/filing/0001564590-22-022999.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681087/000156459022022999/0001564590-22-022999-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681087/000156459022022999/avro-8k_20220608.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:48:29.641484+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}